한글목차

B형 및 C형 간염 진단 시장(2024-2028년)

B형 및 C형 간염 진단 시장은 2023-2028년 30억 2,040만 달러 규모에 달할 것으로 예상되며, 예측 기간 동안 8.09%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 B형 및 C형 간염 진단 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공하며, HBV 및 HCV 진단에서 분자진단에 대한 수요 증가, 진단 프로세스 간소화를 위한 의료기관의 전략, POC 진단에 대한 수요 증가 등이 시장을 주도하고 있습니다.

이 보고서는 HBV 및 HCV 진단 테스트에서 면역 센서의 등장이 향후 몇 년 동안 B형 및 C형 간염 진단 시장 성장을 주도할 주요 요인 중 하나라고 분석했습니다. 또한, 바이오마커 기반 검사에 대한 높은 수요와 HBV 및 HCV 진단 검사에 대한 인식이 높아짐에 따라 시장 수요가 크게 증가할 것으로 예상했습니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장 전망 2023-2028년

제4장 시장 규모 실적

• B형 및 C형 간염 진단 세계 시장 2018-2022년
• 유형별 부문 분석 2018-2022년
• 질병 유형별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 유형별

• 시장 세분화
• 비교 : 유형별
• 면역진단 : 시장 규모와 예측 2023-2028년
• NAT : 시장 규모와 예측 2023-2028년
• 시장 기회 : 유형별

제7장 시장 세분화 : 질환 유형별

• 시장 세분화
• 비교 : 질환 유형별
• B형 간염 : 시장 규모와 예측 2023-2028년
• C형 간염 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 질환 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 영국 : 시장 규모와 예측 2023-2028년
• 일본 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제11장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Abbott Laboratories
• Bio Rad Laboratories Inc.
• bioMerieux SA
• DAAN Gene Co. Ltd.
• DiaSorin SpA
• Enzo Biochem Inc.
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Hologic Inc.
• MedMira Inc.
• OraSure Technologies Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Randox Laboratories Ltd.
• Siemens AG

제13장 부록

영문목차

Hepatitis B and C Diagnostics Market 2024-2028

The hepatitis B and C diagnostics market is forecasted to grow by USD 3020.4 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the hepatitis B and C diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for molecular diagnostics in diagnosis of HBV and HCV, strategies of healthcare organizations toward simplifying diagnostic process, and rising demand for POC diagnostics.

Technavio's hepatitis B and C diagnostics market is segmented as below:

By Type

• Immunodiagnostics
• NAT

By Disease Type

• Hepatitis B
• Hepatitis C

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of immunosensors in HBV and HCV diagnostic tests as one of the prime reasons driving the hepatitis B and C diagnostics market growth during the next few years. Also, high demand for biomarker-based tests and increasing awareness of hbv and hcv diagnostic tests will lead to sizable demand in the market.

The report on the hepatitis B and C diagnostics market covers the following areas:

• Hepatitis B and C diagnostics market sizing
• Hepatitis B and C diagnostics market forecast
• Hepatitis B and C diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B and C diagnostics market vendors that include Abbott Laboratories, Bio RAD Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN NV, Quidelortho Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltd.. Also, the hepatitis B and C diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Hepatitis B And C Diagnostics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hepatitis B And C Diagnostics Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Immunodiagnostics - Market size and forecast 2023-2028
  • Chart on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
  • Chart on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
  • Data Table on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
• 6.4 NAT - Market size and forecast 2023-2028
  • Chart on NAT - Market size and forecast 2023-2028 ($ million)
  • Data Table on NAT - Market size and forecast 2023-2028 ($ million)
  • Chart on NAT - Year-over-year growth 2023-2028 (%)
  • Data Table on NAT - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Disease Type

• 7.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
• 7.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 7.3 Hepatitis B - Market size and forecast 2023-2028
  • Chart on Hepatitis B - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hepatitis B - Market size and forecast 2023-2028 ($ million)
  • Chart on Hepatitis B - Year-over-year growth 2023-2028 (%)
  • Data Table on Hepatitis B - Year-over-year growth 2023-2028 (%)
• 7.4 Hepatitis C - Market size and forecast 2023-2028
  • Chart on Hepatitis C - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hepatitis C - Market size and forecast 2023-2028 ($ million)
  • Chart on Hepatitis C - Year-over-year growth 2023-2028 (%)
  • Data Table on Hepatitis C - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
• 12.4 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
• 12.5 bioMerieux SA
  • bioMerieux SA - Overview
  • bioMerieux SA - Product / Service
  • bioMerieux SA - Key news
  • bioMerieux SA - Key offerings
• 12.6 DAAN Gene Co. Ltd.
  • DAAN Gene Co. Ltd. - Overview
  • DAAN Gene Co. Ltd. - Product / Service
  • DAAN Gene Co. Ltd. - Key offerings
• 12.7 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
• 12.8 Enzo Biochem Inc.
  • Enzo Biochem Inc. - Overview
  • Enzo Biochem Inc. - Product / Service
  • Enzo Biochem Inc. - Key news
  • Enzo Biochem Inc. - Key offerings
• 12.9 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.10 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key news
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus
• 12.11 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Business segments
  • Hologic Inc. - Key news
  • Hologic Inc. - Key offerings
  • Hologic Inc. - Segment focus
• 12.12 MedMira Inc.
  • MedMira Inc. - Overview
  • MedMira Inc. - Product / Service
  • MedMira Inc. - Key offerings
• 12.13 OraSure Technologies Inc.
  • OraSure Technologies Inc. - Overview
  • OraSure Technologies Inc. - Business segments
  • OraSure Technologies Inc. - Key news
  • OraSure Technologies Inc. - Key offerings
  • OraSure Technologies Inc. - Segment focus
• 12.14 PerkinElmer Inc.
  • PerkinElmer Inc. - Overview
  • PerkinElmer Inc. - Business segments
  • PerkinElmer Inc. - Key news
  • PerkinElmer Inc. - Key offerings
  • PerkinElmer Inc. - Segment focus
• 12.15 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
• 12.16 Randox Laboratories Ltd.
  • Randox Laboratories Ltd. - Overview
  • Randox Laboratories Ltd. - Product / Service
  • Randox Laboratories Ltd. - Key news
  • Randox Laboratories Ltd. - Key offerings
• 12.17 Siemens AG
  • Siemens AG - Overview
  • Siemens AG - Business segments
  • Siemens AG - Key news
  • Siemens AG - Key offerings
  • Siemens AG - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
  • 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations